Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers.
Reininger KA, Onyeaghala G, Anderson-Haag T, Schladt DS, Wu B, Guan W, Dorr CR, Remmel RP, Mannon R, Matas AJ, Oetting WS, Stahler P, Israni AK, Jacobson PA.
Reininger KA, et al. Among authors: guan w.
Clin Transplant. 2023 Apr;37(4):e14893. doi: 10.1111/ctr.14893. Epub 2023 Jan 11.
Clin Transplant. 2023.
PMID: 36571802
Free PMC article.